severe congenital neutropenia scn also often known kostmann syndrome disease group rare disorders affect myelopoiesis causing congenital form neutropenia usually without physical malformations scn manifests infancy lifethreatening bacterial causes severe pyogenic infections caused autosomal dominant inheritance elane gene autosomal recessive inheritance gene increased risk leukemia myelodysplastic cancers cases scn respond treatment granulocyte colonystimulating factor filgrastim increases neutrophil count decreases severity frequency although treatment significantly improved survival people scn risk longterm complications hematopoietic clonal disorders myelodysplastic syndrome acute myeloid leukemia kostmann disease initial subtype recognized clinically described type autosomal recessive inheritance pattern whereas common subtype shows autosomal dominant inheritance infants scn frequent infections significant infection within one month others six etiology usually bacterial especially staphylococcal commonly involve abscesses cutaneous internal organs pneumonia mastoiditis inflammation mastoid process sepsis lifethreatening kostmann disease inherited autosomal recessive manner commonest subtype kostmann syndrome autosomal significant proportion scn lacks known recognized subtypes kostmann syndrome scn occasionally may arise sbds severe congenital neutropenia scn used overarching term diseases affect myelopoiesis prominently kostmann syndrome restrictively refer kostmann disease specifically used synonymously scn umbrella term syndrome subtypes phenotypically similar despite arising different gene kostmann disease form severe congenital neutropenia scn specifically type rare autosomal recessive condition severe chronic neutropenia detected soon disorder discovered extended family northern sweden rolf kostmann swedish although mutations genes cause severe congenital neutropenia general usually considered scn clinical usage excludes two broad categories congenital neutropenia diseases excluded overtly affect multiple systems rather impacting myelopoiesis prominently thus scn excludes severe neutropenia occur congenital diseases syndrome barth syndrome syndrome whim syndrome glycogen storage disease type group miscellaneous inherited disorders hyper igm syndrome syndrome hps griscelli syndrome gs pn deficiency cohen syndrome disease cmt show congenital neutropenia lack bone marrow findings typical scncitation needed group diseases may also additional features partial albinism retinopathy neuropathy inclined degenerate acute myelogenous deficiency grouping several disorders caused common defect viz familial sporadic inactivating mutations one two parental genes autosomal dominant mutations cause reduction ie haploinsufficiency cellular levels genes product protein transcription factor critical embryonic development maintenance functionality bloodforming lympathicforming tissueforming stem cells consequence mutations cellular levels deficient individuals develop time hematological immunological lymphatic presentations may begin apparently benign abnormalities commonly progress serious disorder small significant percentage individuals deficiencys present congenital neutropenia neutropenia typically mild often persists years therefore kostmann syndrome disorder time however deficiency commonly progresses include thrombocytopenia increases susceptibility infections due eg atypical mycobacteria human papillomavirus dysfunction nonhematological organs myelodysplastic syndrome andor leukemia particularly acute myelogenous various mutations responsible untimely initiation apoptosis myelocytes usually promyelocyte stage leading premature destruction maturation arrest bone ineffective production neutrophils leads decrease absolute neutrophil count subsequent increased susceptibility infections may addition underlying moleculargenetic changes producing dna mutations genome instability contribute initiation progression diseasecitation needed absolute neutrophil count anc chronically less usually less main sign kostmanns elements include severity neutropenia chronology birth emerging later normal findings hemoglobin platelets general body health isolated neutropenia infants occur viral infections autoimmune neutropenia infancy bone marrow suppression drug toxin hypersplenism passive placental transfer maternal bone marrow test assist diagnosis bone marrow usually shows early granulocyte precursors myelopoietic development stops arrests promyelocyte andor myelocyte stage maturing forms seen neutrophil survival normalcitation needed regular administration exogenous granulocyte colonystimulating factor filgrastim clinically improves neutrophil counts immune function mainstay therapy although may increase risk myelofibrosis acute myeloid leukemia long scn responds treatment granulocyte colonystimulating factor filgrastim significantly improved survivalcitation needed httpsenwikipediaorgwikiseverecongenitalneutropenia